{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T20:01:52Z","timestamp":1780948912144,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005977","name":"Kaiser Permanente","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007278","name":"Henry Ford Health System","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["DB-2020C2-20318"],"award-info":[{"award-number":["DB-2020C2-20318"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.japh.2026.103075","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T07:32:23Z","timestamp":1773646343000},"page":"103075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medication adherence and persistence of newly initiated medications in older adults with diabetes"],"prefix":"10.1016","volume":"66","author":[{"given":"Sarah Krahe","family":"Dombrowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3161-5732","authenticated-orcid":false,"given":"Jaejin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2161-9123","authenticated-orcid":false,"given":"Xuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1056-6038","authenticated-orcid":false,"given":"Vanessa A.","family":"Hayduk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Neugebauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2324-6228","authenticated-orcid":false,"given":"Patrick J.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Schmittdiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4222-7046","authenticated-orcid":false,"given":"Stephanie A.","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5527-316X","authenticated-orcid":false,"given":"Andrew J.","family":"Karter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0802-9794","authenticated-orcid":false,"given":"Caryn E.S.","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8272-4448","authenticated-orcid":false,"given":"Andrea E.","family":"Cassidy-Bushrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerissa","family":"Nance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5214-3992","authenticated-orcid":false,"given":"Margaret B.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7054-1409","authenticated-orcid":false,"given":"Lisa K.","family":"Gilliam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7881-8588","authenticated-orcid":false,"given":"Jove","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1721-4104","authenticated-orcid":false,"given":"Eric A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.japh.2026.103075_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2337\/ds18-0033","article-title":"Diabetes management in the elderly","volume":"31","author":"Leung","year":"2018","journal-title":"Diabetes Spectr"},{"issue":"6","key":"10.1016\/j.japh.2026.103075_bib2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s41999-023-00872-0","article-title":"Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper","volume":"14","author":"Van Poelgeest","year":"2023","journal-title":"Eur Geriatr Med"},{"issue":"Supplement_1","key":"10.1016\/j.japh.2026.103075_bib3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc25-S001","article-title":"Improving care and promoting health in populations: Standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.japh.2026.103075_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.36100","article-title":"Glucose-lowering medication classes and cardiovascular outcomes in patients with type 2 diabetes","volume":"8","author":"Neugebauer","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.japh.2026.103075_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.17886","article-title":"Evaluation of out-of-pocket costs and treatment intensification with an SGLT2 inhibitor or GLP-1 RA in patients with type 2 diabetes and cardiovascular disease","volume":"6","author":"Luo","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.japh.2026.103075_bib6","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.7326\/M21-2941","article-title":"First-line therapy for type 2 diabetes with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a cost-effectiveness study","volume":"175","author":"Choi","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.japh.2026.103075_bib7","doi-asserted-by":"crossref","DOI":"10.5888\/pcd17.200244","article-title":"Cost-related nonadherence and mortality in patients with chronic disease: A multiyear investigation, national health interview survey, 2000-2014","volume":"17","author":"Van Alsten","year":"2020","journal-title":"Prev Chronic Dis"},{"issue":"1","key":"10.1016\/j.japh.2026.103075_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MLR.0000000000001458","article-title":"Cost-related medication nonadherence and its risk factors among Medicare beneficiaries","volume":"59","author":"Nekui","year":"2021","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.japh.2026.103075_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/dom.14603","article-title":"Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: a systematic literature review","volume":"24","author":"Evans","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.japh.2026.103075_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjopharm.2011.02.004","article-title":"A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity","volume":"9","author":"Gellad","year":"2011","journal-title":"Am J Geriatr Pharmacother"},{"issue":"3","key":"10.1016\/j.japh.2026.103075_bib11","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2337\/dc21-1757","article-title":"Cost-related medication nonadherence in adults with diabetes in the United States: The national health interview survey 2013-2018","volume":"45","author":"Taha","year":"2022","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.japh.2026.103075_bib12","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1185\/03007995.2015.1053048","article-title":"Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes","volume":"31","author":"Iglay","year":"2015","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"10.1016\/j.japh.2026.103075_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049130","article-title":"Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review","volume":"11","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2021","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.japh.2026.103075_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.japh.2021.12.001","article-title":"Factors associated with early nonpersistence among patients experiencing side effects from a new medication","volume":"62","author":"Alefan","year":"2022","journal-title":"J Am Pharm Assoc"},{"issue":"11","key":"10.1016\/j.japh.2026.103075_bib15","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2337\/dc16-1925","article-title":"Association between adherence to pharmacotherapy and outcomes in type 2 diabetes: a meta-analysis","volume":"40","author":"Khunti","year":"2017","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.japh.2026.103075_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1377\/hlthaff.2020.01470","article-title":"Actualizing better health and health care for older adults","volume":"40","author":"Fulmer","year":"2021","journal-title":"Health Aff"},{"issue":"10","key":"10.1016\/j.japh.2026.103075_bib17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/ggi.12616","article-title":"Systematic review of the barriers affecting medication adherence in older adults","volume":"16","author":"Yap","year":"2016","journal-title":"Geriatr Gerontol Int"},{"issue":"4","key":"10.1016\/j.japh.2026.103075_bib18","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.japh.2022.03.011","article-title":"Adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments among older patients","volume":"62","author":"Paranjpe","year":"2022","journal-title":"J Am Pharm Assoc"},{"issue":"8","key":"10.1016\/j.japh.2026.103075_bib19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.sapharm.2024.04.013","article-title":"Impact of cost on prescribing diabetes medications for older adults with type 2 diabetes in the outpatient setting","volume":"20","author":"Lussier","year":"2024","journal-title":"Res Soc Adm Pharm"},{"issue":"7","key":"10.1016\/j.japh.2026.103075_bib20","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/03007995.2017.1320277","article-title":"Adherence and persistence in patients with type 2 diabetes mellitus newly initiating canagliflozin, dapagliflozin, dpp-4s, or glp-1s in the United States","volume":"33","author":"Cai","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.japh.2026.103075_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.pcd.2024.06.013","article-title":"Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide versus DPP-4is in a US real-world setting","volume":"18","author":"Lv","year":"2024","journal-title":"Prim Care Diabetes"},{"issue":"4","key":"10.1016\/j.japh.2026.103075_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.japh.2026.103075_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/pds.4403","article-title":"Primary non-adherence and the new-user design","volume":"27","author":"Li","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.japh.2026.103075_bib25","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2147\/PPA.S277676","article-title":"Real-world adherence and discontinuation of glucagon-like peptide-1 receptor agonists therapy in type 2 diabetes mellitus patients in the United States","volume":"14","author":"Weiss","year":"2020","journal-title":"Patient Prefer Adherence"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2026.103075_bib26","first-page":"S193","article-title":"Diabetes care in the hospital: Standards of medical care in Diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"issue":"8Suppl 3","key":"10.1016\/j.japh.2026.103075_bib27","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","article-title":"Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases","volume":"51","author":"Raebel","year":"2013","journal-title":"Med Care"},{"issue":"11","key":"10.1016\/j.japh.2026.103075_bib28","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/MLR.0b013e31817924d2","article-title":"An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients","volume":"46","author":"Karve","year":"2008","journal-title":"Med Care"},{"key":"10.1016\/j.japh.2026.103075_bib29","series-title":"Proportion of days covered (PDC) as a preferred method of measuring medication adherence","author":"Nau","year":"2011"},{"issue":"5p1","key":"10.1016\/j.japh.2026.103075_bib30","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.1475-6773.2009.00989.x","article-title":"New prescription medication gaps: A comprehensive measure of adherence to new prescriptions","volume":"44","author":"Karter","year":"2009","journal-title":"Health Serv Res"},{"issue":"10","key":"10.1016\/j.japh.2026.103075_bib31","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1111\/dom.15809","article-title":"Medication adherence to sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists: a meta-analysis","volume":"26","author":"Johnson","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.japh.2026.103075_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.16290","article-title":"Association of prescription co-payment with adherence to glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter-2 inhibitor therapies in patients with heart failure and diabetes","volume":"6","author":"Essien","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.japh.2026.103075_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.37765\/ajmc.2021.88664","article-title":"Association of co-pay elimination with medication adherence and total cost","volume":"27","author":"Cong","year":"2021","journal-title":"Am J Manag Care"},{"issue":"1","key":"10.1016\/j.japh.2026.103075_bib34","first-page":"4","article-title":"Cost-sharing and adherence, clinical outcomes, health care utilization, and costs: A systematic literature review","volume":"29","author":"Fusco","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"10.1016\/j.japh.2026.103075_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0342056","article-title":"Medication adherence trajectories and association with risk factors and clinical outcomes in type 2 diabetes treatment","volume":"21","author":"Mucherino","year":"2026","journal-title":"PLoS One"},{"key":"10.1016\/j.japh.2026.103075_bib36","doi-asserted-by":"crossref","DOI":"10.3399\/BJGPO.2025.0243","article-title":"Factors affecting the likelihood of documented medication concerns in patients with multimorbidity: a cross-sectional study in primary care [e-pub ahead of print]","author":"Gefaell Larrondo","year":"2026","journal-title":"BJGP Open"},{"key":"10.1016\/j.japh.2026.103075_bib37","article-title":"Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes","volume":"34","author":"Rodriguez","year":"2024","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"10.1016\/j.japh.2026.103075_bib38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00125-024-06321-2","article-title":"Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013-2019","volume":"68","author":"Wang","year":"2025","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.japh.2026.103075_bib39","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/CIRCULATIONAHA.113.002658","article-title":"Racial\/ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare part D beneficiaries after acute myocardial infarction","volume":"129","author":"Lauffenburger","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.japh.2026.103075_bib40","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s11606-013-2692-x","article-title":"Race\/ethnicity, disability, and medication adherence among Medicare beneficiaries with heart failure","volume":"29","author":"Zhang","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.japh.2026.103075_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5993\/AJHB.38.1.6","article-title":"Using quantile regression to assess disparities in medication adherence","volume":"38","author":"Juarez","year":"2014","journal-title":"Am J Health Behav"},{"issue":"9","key":"10.1016\/j.japh.2026.103075_bib42","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1007\/s12325-022-02181-7","article-title":"Preference for Type 2 diabetes therapies in the United States: a discrete choice experiment","volume":"39","author":"Shubrook","year":"2022","journal-title":"Adv Ther"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126000609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126000609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T19:37:55Z","timestamp":1780947475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319126000609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1544319126000609"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2026.103075","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication adherence and persistence of newly initiated medications in older adults with diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2026.103075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103075"}}